Table II.
Clinical information and samples size for TCGA ESCC datasets.
| Variables | Total cases, n=312 (%) | Alive, n=138 (%) | Deceased, n=174 (%) |
|---|---|---|---|
| Sex | |||
| Male | 211 (67.63) | 83 (60.14) | 128 (73.56) |
| Female | 101 (32.37) | 55 (39.86) | 46 (26.44) |
| Race | |||
| White | 162 (51.92) | 5 (39.86) | 107 (61.49) |
| Asia | 127 (40.71) | 68 (49.28) | 59 (33.91) |
| Black | 23 (7.37) | 15 (10.87) | 8 (4.60) |
| Age, years | |||
| ≤50 | 86 (27.56) | 53 (38.41) | 33 (18.97) |
| >50 | 226 (72.44) | 85 (61.59) | 141 (81.03) |
| Tumor grade | |||
| GI | 49 (15.71) | 31 (22.46) | 18 (10.34) |
| GII | 146 (46.79) | 48 (34.78) | 98 (56.32) |
| GIII–IV | 117 (37.50) | 59 (42.75) | 58 (33.33) |
| TNM stage | |||
| I/II | 99 (31.73) | 30 (21.74) | 69 (39.66) |
| III/IV | 213 (68.27) | 108 (78.26) | 105 (60.34) |
| Lymph node status | |||
| No metastasis | 35 (11.22) | 32 (23.19) | 3 (1.72) |
| Metastasis | 277 (88.78) | 106 (76.81) | 171 (98.28) |
TCGA, The Cancer Genome Atlas; ESCC, esophageal squamous cell carcinoma.